Massachusetts Financial Services’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-105,285
Closed -$13.6M 911
2020
Q3
$13.6M Sell
105,285
-20,630
-16% -$2.27M ﹤0.01% 604
2020
Q2
$11M Sell
125,915
-6,391
-5% -$491K ﹤0.01% 602
2020
Q1
$7.97M Sell
132,306
-39,547
-23% -$2.93M ﹤0.01% 606
2019
Q4
$12.8M Buy
171,853
+53
+0% +$3.41K ﹤0.01% 580
2019
Q3
$10.5M Sell
171,800
-647
-0.4% -$42.6K ﹤0.01% 604
2019
Q2
$10.5M Buy
172,447
+44,932
+35% +$2.42M ﹤0.01% 620
2019
Q1
$7.24M Sell
127,515
-85
-0.1% -$4.59K ﹤0.01% 637
2018
Q4
$5.39M Buy
127,600
+2,632
+2% +$112K ﹤0.01% 655
2018
Q3
$5.26M Sell
124,968
-19
-0% -$892 ﹤0.01% 674
2018
Q2
$4.46M Buy
+124,987
New +$4.03M ﹤0.01% 675

Other funds holding INSP

Massachusetts Financial Services's INSP Position: Q4 2020 in Review

Massachusetts Financial Services sold out of Inspire Medical Systems (INSP) in Q4 2020, closing a stake of 105,285 shares — an estimated $13.6M sold.

Massachusetts Financial Services first reported a position in INSP in Q2 2018 and held it in 10 quarters. The position peaked at $13.6M in Q3 2020. 239 funds tracked by Wall St. Rank hold INSP as of Q4 2020.

  • Massachusetts Financial Services reported no remaining Inspire Medical Systems position as of Q4 2020 after selling out during the quarter.
  • Massachusetts Financial Services sold 105,285 Inspire Medical Systems shares in Q4 2020, an estimated $13.6M.
  • Massachusetts Financial Services first reported a position in Inspire Medical Systems in Q2 2018 and held it in 10 quarters.
  • Massachusetts Financial Services's Inspire Medical Systems position peaked at $13.6M in Q3 2020.
  • 239 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q4 2020.

Based on Massachusetts Financial Services's 13F filing for Q4 2020, filed 12 Feb 2021.